IMIDEX’s CEO Richard Vlasimsky was interviewed by KOA 850AM radio in Denver to discuss the recent FDA clearance of VisiRad XR and how the use of AI tools like VisiRad XR can help identify potential lung cancers. Listen to the segment below: